Homocysteine: The Missing Biomarker in Preventive Medicine

Homocysteine, a sulfur-containing amino acid formed during methionine metabolism, has emerged as one of the most clinically significant yet underutilized biomarkers in laboratory medicine.

In adults, fasting total plasma homocysteine is commonly reported in the range of approximately 5–15 µmol/L.

Levels above the laboratory’s upper reference limit are generally described as hyperhomocysteinemia. Over the past two decades, growing scientific evidence has demonstrated that it is associated with an increased risk of coronary artery disease, stroke, peripheral vascular disease, cognitive decline, Alzheimer’s disease, recurrent pregnancy loss, neural tube defects, osteoporosis and several chronic metabolic disorders.

It is also recognised as a sensitive functional marker of vitamin B12, folate and vitamin B6 deficiency,An elevated homocysteine concentration can provide an important clue to an underlying functional deficiency of B12 or folate, sometimes even when the clinical manifestations of deficiency are not yet obvious.

Unlike many disease biomarkers that merely indicate risk, homocysteine offers an important clinical advantage—it is modifiable. In many patients, elevated homocysteine levels can be effectively reduced by correcting deficiencies of folate, vitamin B12 and vitamin B6, along with appropriate dietary and lifestyle interventions. This makes homocysteine a valuable biomarker not only for risk assessment, but also for monitoring response to therapy and evaluating nutritional intervention.

For laboratory professionals, homocysteine presents a unique analytical challenge. Following blood collection, erythrocytes continue to produce and release homocysteine, leading to a progressive increase in measured concentrations if plasma is not separated promptly. Consequently, the reliability of homocysteine testing depends as much on meticulous pre-analytical handling as on assay performance itself.

As healthcare moves towards predictive and preventive medicine, laboratories have an increasingly important role in providing biomarkers that enable earlier identification of disease risk. For laboratories, however, the clinical value of any biomarker ultimately depends on the availability of a test that delivers accurate, reliable and reproducible results.

AGD offers a Homocysteine Assay designed to provide accurate and reliable measurement, while offering an economical testing solution for routine laboratory use. This enables laboratories to incorporate homocysteine testing into their diagnostic menu while maintaining a balance between quality, performance and cost-effectiveness.

In this edition of AGD Science Newsletters, we explore the science behind homocysteine through a series of practical questions that every laboratory and IVD professional should know.